Literature DB >> 3044573

Endocrine differentiation of gastric adenocarcinoma. The prevalence as evaluated by immunoreactive chromogranin A and its biologic significance.

A Ooi1, M Mai, T Ogino, H Ueda, T Kitamura, Y Takahashi, E Kawahara, I Nakanishi.   

Abstract

The prevalence of endocrine differentiation of conventional gastric adenocarcinoma was evaluated on the 212 cases (including 62 mucosal carcinomas) of consecutively resected stomach for adenocarcinoma in our hospital using anti-chromogranin A (CGA) antibodies. CGA-positive cells were found in 28 of 150 cases (18.7%) as an integral tumor component. In immunocytochemistry and electron microscopic examinations, we could classify these 28 cases into three groups according to the distribution patterns of CGA-positive cells. The first group consisted of 12 cases in which scattered CGA-positive cells were located in neoplastic glands. The second group consisted of six cases of scirrhous carcinoma in which CGA-positive cells were separated by fibrovascular tissue. The third group consisted of ten cases in which the positive cells were present in clusters. No definite correlation was recognized between the appearance of CGA cells and histologic types of predominance. In the analysis of the hormonal substances coexpressed by CGA-positive cells, immunoreactive serotonin (SER) was found most frequently, and somatostatin (SS), gastrin (GAS), glucagon/glicentin (GLU/GLI), and peptide-tyrosine-tyrosine (PYY) like immunoreactivities were found in a few tumor cells. CGA-positive cells occupied limited parts of the tumors in most cases, and they were noticeably more frequent in advanced stage cases. This might explain why endocrine differentiation reflects the dysexpression of the neoplastic stem cells. Furthermore, absence of mitotic figures in this type of cell and negativity of a single colony composed exclusively of CGA cells in metastatic foci suggested that these cells are in a dormant phase and are probably postmitotic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044573     DOI: 10.1002/1097-0142(19880915)62:6<1096::aid-cncr2820620612>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component.

Authors:  J P Brouland; P Manivet; I Brocheriou-Spelle; M Wassef; M F Le Bodic; A Lavergne; J M Launay
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.

Authors:  Lois Jessen; Lawrence J Kovalick; Albert J Azzaro
Journal:  P T       Date:  2008-04

3.  Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.

Authors:  Olga Speck; Weihua Tang; Douglas R Morgan; Pei Fen Kuan; Michael O Meyers; Ricardo L Dominguez; Enrique Martinez; Margaret L Gulley
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-10

Review 4.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

5.  Expression of somatostatin mRNA in various differentiated types of gastric carcinoma.

Authors:  Qin-Xian Zhang; Ying-Li Dou; Xue-Yi Shi; Yi Ding
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

6.  Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas.

Authors:  Aping Yuan; Jinzhong Liu; Yiqing Liu; Guanglin Cui
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

7.  Prognostic role of neuroendocrine cell differentiation in human gastric carcinoma.

Authors:  Tingting Zhang; Dan Su; Zhiyuan Mao; Xiaochuan Guo; Lijie Wang; Li Bai
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications.

Authors:  Cigdem Celikel; Funda Eren; Bahadir Gulluoglu; Nural Bekiroglu; Serdar Turhal
Journal:  Pathol Oncol Res       Date:  2007-10-07       Impact factor: 3.201

9.  Primary mixed neuroendocrine and mucinous carcinoma of the ovary.

Authors:  R J Collins; A Cheung; H Y Ngan; L C Wong; S Y Chan; H K Ma
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

10.  An Unusual Case of Multiple Gastric Carcinoids Associated with Diffuse Endocrine Cell Hyperplasia and Parietal Cell Hypertrophy.

Authors:  Akishi Ooi; Masako Ota; Shogo Katsuda; Isao Nakanishi; Hiroyuki Sugawara; Ichiro Takahashi
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.